PDL‐1 or PDL‐2 expressed on tumor cells can bind to the receptor PD1 found on T cells and attenuate T cell activation, proliferation, and cytotoxic secretion leading to impaired anti‐tumor immune responses.5 This evidence concerns the gene PDCD1LG2 and neoplasm.